ARTICLE | Clinical News
Ushercell: Phase II started
March 22, 2004 8:00 AM UTC
POLXF started a 6-month, open-label, U.S. Phase II trial in 200 couples who currently do not desire a pregnancy and who are at low risk for sexually transmitted infections. ...